{"symbol":"AVTX","name":"Avalo Therapeutics, Inc.","sector":"Healthcare","industry":"Biotechnology","currency":"USD","reportedCurrency":"USD","asOf":{"dataUpdatedAt":"2026-10-06T09:12:37.353Z","note":"lastClose is the verified official regular-session close; latestPrice is a regular-session quote and may be delayed. Fundamentals are trailing-twelve-month unless suffixed otherwise."},"price":{"lastClose":14.6,"lastCloseDate":"2026-10-05","latestPrice":13.3717,"priceSource":"fmp-delayed","change":-1.228299999999999,"changePercent":-8.413013698630131,"marketCap":702891434,"high52Week":24.27,"low52Week":12.51,"returnYtdPercent":-19.6,"return1YPercent":8.96},"valuation":{"peRatio":null,"peRatioForward":null,"psRatio":11913.41,"pbRatio":1.57,"pfcfRatio":null,"pegRatio":null,"evToEbitda":null,"evToSales":10470.36,"earningsYieldPercent":null,"fcfYieldPercent":null},"profitability":{"grossMarginPercent":100,"operatingMarginPercent":-123601.69,"netMarginPercent":-170055.93,"roePercent":-22.36,"roaPercent":-20.44,"roicPercent":-19.45},"financialHealth":{"currentRatio":19.31,"quickRatio":19.31,"debtToEquity":0,"interestCoverage":null},"dividends":{"yieldPercent":null,"payoutRatioPercent":null,"dividendPerShare":null,"consecutiveYears":0},"growthCagrPercent":{"revenue":{"y3":-84.84,"y5":-60.88,"y10":-21.34},"grossProfit":{"y3":null,"y5":null,"y10":null},"netIncome":{"y3":null,"y5":null,"y10":null},"eps":{"y3":null,"y5":null,"y10":null},"freeCashFlow":{"y3":null,"y5":null,"y10":null},"dividends":{"y3":null,"y5":null,"y10":null},"totalReturn":{"y3":-27.4,"y5":-70.04,"y10":-48.7}},"links":{"overview":"https://tgmcharts.com/stocks/AVTX","metrics":"https://tgmcharts.com/stocks/AVTX/metrics","financials":"https://tgmcharts.com/stocks/AVTX/financials","docs":"https://tgmcharts.com/llms.txt"},"applicability":{"freeCashFlow":"applicable","enterpriseValue":"applicable","earnings":"applicable"},"classification":{"type":"operating","flags":{"adr":false,"foreignFiler":false,"semiannualReporter":false,"fund":false}}}